Tue, Oct 18, 2022 11:00 AM – 12:00 PM EDT
Presenter: Joseph Zabinski, Senior Director, AI & Precision Medicine, OM1
As population health moves towards personalized, precision medicine, optimizing treatment options and reducing ineffective care will be critical to plans’ success and differentiation in highly competitive environments. Real-world evidence drawn from deep datasets can provide insights beyond what’s available from claims data alone, and AI methods can help operationalize these insights to make real, positive differences in member outcomes.
In this webinar we will focus on concrete ways that RWE and AI can move the needle for health plans, and help accelerate progress towards true personalized medicine. Areas of discussion include:
- The added insight and value generated for plans by augmenting claims data with additional real-world data sources
- How AI can generate personalized decision-support metrics for members – for example, around likelihood of benefit from particular treatments
- The promise of digital phenotyping, and how it can provide visibility into members’ risks and future trajectories beyond what’s visible ‘at the surface’
The challenge for health plans in using RWE and AI is often greatest at the beginning – knowing where to start, with a clear path towards positive impact. This webinar will provide clarity and actionable steps health plan leaders can take to capture this emerging value.
**Please be advised this webinar is intended for health plan, pharmaceutical and medical device companies. Due to the proprietary nature of the content, all registration approval is at the discretion of OM1. Vendors and consultants will not be permitted to attend at this time.